FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200214410> ?p ?o ?g. }

• W4200214410 endingPage "56" @default.
• W4200214410 startingPage "49" @default.
• W4200214410 abstract "To investigate whether physical activity is associated with enhanced immunogenicity of a SARS-CoV-2 inactivated vaccine (Coronavac) in patients with autoimmune rheumatic diseases (ARD) (n = 898) and in non-ARD (n = 197) individuals without pre-existing immunogenicity to SARS-CoV-2.This was a prospective cohort study within an open-label, single-arm, phase 4 vaccination trial. Immunogenicity was assessed after vaccination by measuring seroconversion rates of total anti-SARS-CoV-2 S1/S2 IgG (SC), geometric mean titers of anti-S1/S2 IgG (GMT), factor-increase in GMT (FI-GMT), frequency of neutralizing antibody (NAb), and median neutralizing activity. Physical activity (active being defined as ≥ 150 min/week) and sedentary behavior (>8h/day) were assessed by questionnaire.Physically active ARD patients (n = 494) were younger and less frequently used prednisone/biologics than inactive patients (n = 404). After controlling for covariates, active patients exhibited greater SC (OR: 1.4 [95%CI: 1.1-2.0]), GMT (32% [95%CI: 8.8-60) and FI-GMT (33% [95%CI: 9.6-63%]) vs. inactive. Cluster analysis (physical activity/sedentary status) revealed greater GMT (43.0% [95% CI: 11.0-84.0%) and FI-GMT (48.0% [95%CI: 14.0-92.0%]) in active/non-sedentary vs. inactive/sedentary ARD patients. A dose-response was observed, with greater benefits for the group of patients performing ≥ 350 min/week of physical activity (OR: 1.6 [95%CI: 1.1-2.4]; 41% [95%CI: 10-80%]; 35% [95%CI: 4.3-74], for SC, GMT, and FI-GMT, respectively) vs. the least active group (≤30 min/week). Greater SC (OR: 9.9 [95%CI: 1.1-89.0]) and GMT (26% [95%CI: 2.2-56.0%]) were observed in active vs. inactive non-ARD.A physically active lifestyle may enhance SARS-CoV-2 vaccine immunogenicity, a finding of particular clinical relevance for immunocompromised patients.Clinicaltrials.gov #NCT04754698." @default.
• W4200214410 created "2021-12-31" @default.
• W4200214410 creator A5000148954 @default.
• W4200214410 creator A5002652877 @default.
• W4200214410 creator A5005567201 @default.
• W4200214410 creator A5015484380 @default.
• W4200214410 creator A5015977988 @default.
• W4200214410 creator A5042325405 @default.
• W4200214410 creator A5051023997 @default.
• W4200214410 creator A5052027044 @default.
• W4200214410 creator A5057820606 @default.
• W4200214410 creator A5059022454 @default.
• W4200214410 creator A5063666934 @default.
• W4200214410 creator A5065995960 @default.
• W4200214410 creator A5075963523 @default.
• W4200214410 creator A5080632302 @default.
• W4200214410 creator A5081589721 @default.
• W4200214410 creator A5082731917 @default.
• W4200214410 creator A5088093249 @default.
• W4200214410 date "2022-03-01" @default.
• W4200214410 modified "2023-10-14" @default.
• W4200214410 title "Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases" @default.
• W4200214410 cites W1520061174 @default.
• W4200214410 cites W1993444330 @default.
• W4200214410 cites W2020740829 @default.
• W4200214410 cites W2029902970 @default.
• W4200214410 cites W2045429846 @default.
• W4200214410 cites W2046233961 @default.
• W4200214410 cites W2049928147 @default.
• W4200214410 cites W2054699137 @default.
• W4200214410 cites W2061370819 @default.
• W4200214410 cites W2062506845 @default.
• W4200214410 cites W2071493639 @default.
• W4200214410 cites W2076082444 @default.
• W4200214410 cites W2077828153 @default.
• W4200214410 cites W2112141400 @default.
• W4200214410 cites W2121419200 @default.
• W4200214410 cites W2128462675 @default.
• W4200214410 cites W2153802235 @default.
• W4200214410 cites W2154647037 @default.
• W4200214410 cites W2335965827 @default.
• W4200214410 cites W2417465325 @default.
• W4200214410 cites W2936416719 @default.
• W4200214410 cites W3037505531 @default.
• W4200214410 cites W3108106255 @default.
• W4200214410 cites W3111255098 @default.
• W4200214410 cites W3137328974 @default.
• W4200214410 cites W3137814380 @default.
• W4200214410 cites W3139490202 @default.
• W4200214410 cites W3154431393 @default.
• W4200214410 cites W3156459939 @default.
• W4200214410 cites W3158032196 @default.
• W4200214410 cites W3158123254 @default.
• W4200214410 cites W3158276912 @default.
• W4200214410 cites W3158948419 @default.
• W4200214410 cites W3159191704 @default.
• W4200214410 cites W3163785571 @default.
• W4200214410 cites W3179399516 @default.
• W4200214410 cites W3186114398 @default.
• W4200214410 cites W3198878879 @default.
• W4200214410 cites W4205978945 @default.
• W4200214410 doi "https://doi.org/10.1016/j.bbi.2021.12.016" @default.
• W4200214410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34954325" @default.
• W4200214410 hasPublicationYear "2022" @default.
• W4200214410 type Work @default.
• W4200214410 citedByCount "15" @default.
• W4200214410 countsByYear W42002144102022 @default.
• W4200214410 countsByYear W42002144102023 @default.
• W4200214410 crossrefType "journal-article" @default.
• W4200214410 hasAuthorship W4200214410A5000148954 @default.
• W4200214410 hasAuthorship W4200214410A5002652877 @default.
• W4200214410 hasAuthorship W4200214410A5005567201 @default.
• W4200214410 hasAuthorship W4200214410A5015484380 @default.
• W4200214410 hasAuthorship W4200214410A5015977988 @default.
• W4200214410 hasAuthorship W4200214410A5042325405 @default.
• W4200214410 hasAuthorship W4200214410A5051023997 @default.
• W4200214410 hasAuthorship W4200214410A5052027044 @default.
• W4200214410 hasAuthorship W4200214410A5057820606 @default.
• W4200214410 hasAuthorship W4200214410A5059022454 @default.
• W4200214410 hasAuthorship W4200214410A5063666934 @default.
• W4200214410 hasAuthorship W4200214410A5065995960 @default.
• W4200214410 hasAuthorship W4200214410A5075963523 @default.
• W4200214410 hasAuthorship W4200214410A5080632302 @default.
• W4200214410 hasAuthorship W4200214410A5081589721 @default.
• W4200214410 hasAuthorship W4200214410A5082731917 @default.
• W4200214410 hasAuthorship W4200214410A5088093249 @default.
• W4200214410 hasBestOaLocation W42002144102 @default.
• W4200214410 hasConcept C126322002 @default.
• W4200214410 hasConcept C159654299 @default.
• W4200214410 hasConcept C203014093 @default.
• W4200214410 hasConcept C22070199 @default.
• W4200214410 hasConcept C2777451964 @default.
• W4200214410 hasConcept C2778720950 @default.
• W4200214410 hasConcept C2780868878 @default.
• W4200214410 hasConcept C32611913 @default.
• W4200214410 hasConcept C71924100 @default.
• W4200214410 hasConcept C72563966 @default.
• W4200214410 hasConcept C90924648 @default.

• next